These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26983018)

  • 1. Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland.
    Mankowski C; Patel S; Trueman D; Bentley A; Poole C
    PLoS One; 2016; 11(3):e0150973. PubMed ID: 26983018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
    Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
    Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M; Liedgens H; Nuijten M
    Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
    Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK
    Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
    van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
    Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
    Carlos F; Espejel L; Novick D; López R; Flores D
    Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.
    Cruccu G; Nurmikko TJ; Ernault E; Riaz FK; McBride WT; Haanpää M
    Eur J Pain; 2018 Apr; 22(4):700-706. PubMed ID: 29194851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin.
    Viel E; Eerdekens M; Kandaswamy P
    Pain Physician; 2021 Sep; 24(6):453-463. PubMed ID: 34554688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; Rejas J
    Pain Med; 2012 May; 13(5):699-710. PubMed ID: 22594706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; González-Gómez FJ; Ruiz L; Rejas J
    Prim Care Diabetes; 2012 Dec; 6(4):303-12. PubMed ID: 22595032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
    Bellows BK; Nelson RE; Oderda GM; LaFleur J
    Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model.
    Hirst M; Bending MW; Baio G; Yesufu-Udechuku A; Dunlop WCN
    J Med Econ; 2018 Sep; 21(9):930-935. PubMed ID: 29882452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility of pregabalin as add-on to usual care versus usual care alone in the management of peripheral neuropathic pain in Belgium.
    Chevalier P; Lamotte M; Van Campenhout H; Eyckerman R; Annemans L
    J Med Econ; 2013; 16(5):596-605. PubMed ID: 23409950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
    Burness CB; McCormack PL
    Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain.
    Huygen F; Kern KU; Pérez C
    J Pain Res; 2020; 13():2585-2597. PubMed ID: 33116801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan.
    Akazawa M; Igarashi A; Ebata N; Murata T; Zeniya S; Haga Y; Nozawa K; Fujii K; Taguchi T
    J Pain Res; 2019; 12():2785-2797. PubMed ID: 31576163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
    Bellows BK; Dahal A; Jiao T; Biskupiak J
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):153-64. PubMed ID: 22509775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin 8% dermal patch in clinical practice: an expert opinion.
    Bonezzi C; Costantini A; Cruccu G; Fornasari DMM; Guardamagna V; Palmieri V; Polati E; Zini P; Dickenson AH
    Expert Opin Pharmacother; 2020 Aug; 21(11):1377-1387. PubMed ID: 32511032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.